HCL Technologies surges on partnering with Denodo
HCL Technologies is currently trading at Rs. 1646.35, up by 4.40 points or 0.27% from its previous closing of Rs. 1641.95 on the BSE.
The scrip opened at Rs. 1632.85 and has touched a high and low of Rs. 1655.00 and Rs. 1632.85 respectively. So far 20641 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1696.50 on 23-Feb-2024 and a 52 week low of Rs. 1,115.15 on 03-Aug-2023.
Last one week high and low of the scrip stood at Rs. 1655.00 and Rs. 1591.05 respectively. The current market cap of the company is Rs. 447076.32 crore.
The promoters holding in the company stood at 60.81%, while Institutions and Non-Institutions held 34.24% and 4.95% respectively.
HCL Technologies (HCLTech) has launched advanced clinical trials and diagnosis solution in collaboration with Denodo, a leader in data management and Amazon Web Services (AWS) ecosystem solutions, to accelerate the pace of diagnosis and treatment research.
Leveraging the Denodo Platform -- a logical data integration, data management and data delivery solution on AWS Cloud -- HCLTech has developed data assets that can be integrated into customers’ data analytics landscape for modernized reporting and analysis.
This clinical trials and diagnosis solution helps pharmaceutical companies capture comprehensive data insights from the clinical studies, streamlining clinical trials and enabling quicker and better decision-making. The solution enables healthcare providers to efficiently compare new treatments against standard ones, considering varied dosages and demographic impacts through a centralized data model that is secure with real-time access to critical data.
HCL Technologies is a leading global IT services company that helps global enterprises reimagines and transforms their businesses through digital technology transformation.